Sentence examples for the incremental lifetime from inspiring English sources

We reviewed the literature to identify the best current estimate of the incremental lifetime per capita medical cost of an obese child in the United States today relative to a normal weight child.

CONCLUSIONS: We recommend use of an estimate of $19 000 as the incremental lifetime medical cost of an obese child relative to a normal weight child who maintains normal weight throughout adulthood.

The incremental lifetime direct medical cost from the perspective of a 10-year-old obese child relative to a 10-year-old normal weight child ranges from $12 660 to $19 630 when weight gain through adulthood among normal weight children is accounted for and from $16 310 to $39 080 when this adjustment is not made.

This analysis focuses on estimating the incremental lifetime costs associated with screening previously diagnosed asthmatic subjects.

Economic analysis was performed to estimate the incremental lifetime costs associated with secondary screening of previously diagnosed asthmatic subjects.

For example, Finkelstein et al. estimated that the incremental lifetime medical cost of an obese 10-year-old child in the US, in relation to a normal weight child who maintained normal weight throughout adulthood, was $19,000 [ 4].

Results On the basis of the data in the trial, the estimated mean incremental lifetime cost per person receiving the DESMOND intervention is £209 (95% confidence interval −£704 to £1137€25151, −€844 to €1363; $326, −$1098 to $1773), the incremental gain in QALYs per person is 0.0392 (−0.0813 to 0.1786), and the mean incremental cost per QALY is £5387.

To estimate the expected incremental lifetime cost of treatment of keratoconus compared to the expected cost of the treatment of myopia.

The median Incremental Lifetime Cancer Risk ILCRR) attributable to PAH dietary intake was 6.65 × 10−5 (4.41 × 10−5 to 1.02 × 10−4 as inter-quartile range).

Decisions to scale-up ART across sub-Saharan Africa have been made in the absence of incremental lifetime cost and cost-effectiveness data which seriously limits attempts to secure funds at the global level for HIV treatment or to set priorities at the country level.

We followed Gould's method where estimates of IQ decrement were based on the data from the main published studies [ 16, 17, 35], and we drew from her 2006 estimate of $200617,8155 for the present value of incremental lifetime earnings.